JenniferBrigitteGreenMD

Endocrinology • Durham, NC

Diabetes, Lipid Metabolism

Professor of Medicine, Duke University

Join to view full profile

Dr. Green is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Green's full profile

Already have an account?

Office
200 Morris St., Room 7114
P.O. Box 17969
Durham, NC 27715
Phone+1 919-668-8725

Fax+1 919-668-7055

Education & Training

Duke University HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1996 - 1998
University of North Carolina HospitalsResidency, Internal Medicine, 1993 - 1996
University of Virginia School of MedicineClass of 1993

Certifications & Licensure

NC State Medical License 1996 - 2025
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Clinical Trials

Action to Control Cardiovascular Risk in Diabetes (ACCORD) Start of enrollment: 1999 Sep 01
Completed
Phase 3
Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes Start of enrollment: 2000 Sep 01
Completed
Phase 3
Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy Start of enrollment: 2007 Jan 01
Completed
Not Applicable
Enhancing Fitness in Older Pre-diabetic Veterans Start of enrollment: 2008 Oct 01
Completed
Phase 2, Phase 3
Sitagliptin Cardiovascular Outcomes Study (MK-0431-082) Start of enrollment: 2008 Dec 10
Completed
Phase 3
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus Start of enrollment: 2010 Jun 18
Completed
Phase 3
A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes Start of enrollment: 2013 May 01
Completed
Phase 3
Southeastern Diabetes Initiative Clinical Intervention Start of enrollment: 2013 Apr 01
Completed
Not Applicable
Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes Mellitus Start of enrollment: 2015 Jul 01
Completed
Phase 4
A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes Start of enrollment: 2017 Jan 17
Completed
Phase 3
EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin) Start of enrollment: 2019 Jan 31
COMPLETED
PHASE3
A 12 Month Site Randomized Trial in Adults With Type 2 Diabetes Mellitus and History of Cardiovascular Disease Start of enrollment: 2019 Jul 25
COMPLETED
NA
Join now to see all

Publications & Presentations

PubMed

2 citations
Empagliflozin lowers serum uric acid in chronic kidney disease: exploratory analyses from the EMPA-KIDNEY trial.
Kaitlin J Mayne, Rebecca J Sardell, Natalie Staplin, Parminder K Judge, Doreen Zhu
Nephrology, Dialysis, Transplantation. 2025-04-01
Discontinuation of SGLT-2i and GLP-1RA among persons with Type 2 diabetes and atherosclerotic cardiovascular disease treated in US cardiology clinics.
Adam J Nelson, Lisa A Kaltenbach, Darren K McGuire, Monica Levya, Hussein R Al-Khalidi
American Heart Journal. 2025-04-01
Striving for early effective glycaemic and weight management in type 2 diabetes: A narrative review.
Alice Y Y Cheng, Robert J Heine, Stefano Del Prato, Jennifer B Green, Vivian Thuyanh Thieu
Diabetes, Obesity & Metabolism. 2025-04-01

Journal Articles

Treatment with Incretins Does Not Increase the Risk of Pancreatic Diseases Compared to Older Anti‐Hyperglycaemic Drugs, When Added to Metformin: Real World Evidence in...
Jennifer Green, MD, Diabetic Medicine
Preventing Heart Failure in Diabetes
Adam D DeVore, Jennifer B Green, ScienceDirect

Other

Full list of publications
Jennifer Green, pubmed
https://www.ncbi.nlm.nih.gov/myncbi/1N3tmspW86aAM/bibliography/public/

Authored Content

Endocrine Self-Assessment Program (ESAP) - issues 2013-2017May 2013

Press Mentions

COVID-19 Cases Are Increasing in Cumberland County. Should Residents Be Concerned?July 25th, 2022
Masking to Become Optional in 'Coming Days' for Wake County Public School SystemFebruary 18th, 2022
COVID-19 Vaccination Rates for Children Still Low as Risk RemainsDecember 13th, 2021
Join now to see all